MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19 NEWS PROVIDED BY MilliporeSigma May 27, 2020, 09:15 ET
"Vaccine manufacturing is extremely complicated, so we are collaborating on a process development approach to accelerate manufacturing of Baylor's Covid-19 vaccine candidates," said Udit Batra, CEO, MilliporeSigma. "To fight this pandemic, we will need to produce an unprecedented amount of vaccine in a very short period of time, and we need as many approaches as possible to be successful."